Revolutionizing Preventive Medicine with AI Facial Biometrics: Medical Care Technologies Inc. (OTC Pink:MDCE) Leads the Charge
Medical Care Technologies (OTC Pink:MDCE) has unveiled its revolutionary AI Facial Age-Based Health Risk Estimator, a groundbreaking diagnostic tool that combines artificial intelligence with computer vision for preventive healthcare.
The platform analyzes facial biometric markers including micro-wrinkle density, skin elasticity, and tone variance to estimate biological age and assess risk for chronic conditions like cardiovascular disease and type 2 diabetes. The technology enables real-time, non-invasive screening through mobile apps, marking a shift from reactive to proactive healthcare.
This innovation positions MDCE to capitalize on the global preventive health market, which is projected to surpass $250 billion by 2030.
Medical Care Technologies (OTC Pink:MDCE) ha presentato il suo rivoluzionario AI Facial Age-Based Health Risk Estimator, uno strumento diagnostico innovativo che combina intelligenza artificiale e visione artificiale per la prevenzione sanitaria.
La piattaforma analizza marcatori biometrici facciali come densità delle micro-rughe, elasticità della pelle e variazioni di tonalità per stimare l'età biologica e valutare il rischio di patologie croniche quali malattie cardiovascolari e diabete di tipo 2. Questa tecnologia consente uno screening non invasivo e in tempo reale tramite app mobili, segnando una svolta dalla medicina reattiva a quella proattiva.
Questa innovazione posiziona MDCE per sfruttare il mercato globale della salute preventiva, previsto superare i 250 miliardi di dollari entro il 2030.
Medical Care Technologies (OTC Pink:MDCE) ha presentado su revolucionario AI Facial Age-Based Health Risk Estimator, una herramienta diagnóstica innovadora que combina inteligencia artificial con visión por computadora para la atención preventiva de la salud.
La plataforma analiza marcadores biométricos faciales como densidad de microarrugas, elasticidad de la piel y variación del tono para estimar la edad biológica y evaluar el riesgo de enfermedades crónicas como enfermedades cardiovasculares y diabetes tipo 2. La tecnología permite un cribado no invasivo y en tiempo real a través de aplicaciones móviles, marcando un cambio de la atención reactiva a la proactiva.
Esta innovación posiciona a MDCE para aprovechar el mercado global de salud preventiva, que se proyecta superará los 250 mil millones de dólares para 2030.
Medical Care Technologies (OTC Pink:MDCE)는 인공지능과 컴퓨터 비전을 결합한 혁신적인 진단 도구인 AI Facial Age-Based Health Risk Estimator를 공개했습니다. 이는 예방 의료 분야의 획기적인 기술입니다.
이 플랫폼은 미세 주름 밀도, 피부 탄력성, 톤 변화 등 얼굴의 생체 지표를 분석하여 생물학적 나이를 추정하고 심혈관 질환 및 제2형 당뇨병과 같은 만성 질환 위험을 평가합니다. 이 기술은 모바일 앱을 통해 실시간 비침습적 검사를 가능하게 하여 반응적 의료에서 예방적 의료로의 전환을 의미합니다.
이 혁신은 MDCE가 글로벌 예방 건강 시장을 공략할 수 있는 위치에 있으며, 2030년까지 2500억 달러를 초과할 것으로 예상됩니다.
Medical Care Technologies (OTC Pink:MDCE) a dévoilé son révolutionnaire AI Facial Age-Based Health Risk Estimator, un outil de diagnostic innovant qui combine intelligence artificielle et vision par ordinateur pour la santé préventive.
La plateforme analyse des marqueurs biométriques faciaux tels que la densité des micro-rides, l'élasticité de la peau et la variation de ton pour estimer l'âge biologique et évaluer le risque de maladies chroniques comme les maladies cardiovasculaires et le diabète de type 2. Cette technologie permet un dépistage non invasif en temps réel via des applications mobiles, marquant une transition des soins réactifs aux soins proactifs.
Cette innovation positionne MDCE pour tirer parti du marché mondial de la santé préventive, qui devrait dépasser 250 milliards de dollars d'ici 2030.
Medical Care Technologies (OTC Pink:MDCE) hat seinen revolutionären AI Facial Age-Based Health Risk Estimator vorgestellt, ein bahnbrechendes Diagnosewerkzeug, das künstliche Intelligenz mit Computer Vision für präventive Gesundheitsvorsorge kombiniert.
Die Plattform analysiert biometrische Gesichtsmarker wie Mikofalten-Dichte, Hautelastizität und Tonabweichungen, um das biologische Alter zu schätzen und das Risiko für chronische Erkrankungen wie Herz-Kreislauf-Erkrankungen und Typ-2-Diabetes zu bewerten. Die Technologie ermöglicht eine Echtzeit- und nicht-invasive Untersuchung über mobile Apps und markiert einen Wandel von reaktiver zu proaktiver Gesundheitsversorgung.
Diese Innovation positioniert MDCE, um vom globalen Markt für präventive Gesundheit zu profitieren, der voraussichtlich bis 2030 250 Milliarden US-Dollar übersteigen wird.
- Innovative AI-powered diagnostic tool combining facial biometrics with preventive healthcare
- Mobile app deployment enables scalable, non-invasive screening solution
- Strategic entry into growing preventive health market projected at $250B by 2030
- Early-stage technology without proven clinical validation
- Potential regulatory hurdles for AI-based medical diagnostic tools
- Competitive market with established healthcare technology players
MESA, ARIZONA / ACCESS Newswire / July 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is redefining the future of preventive healthcare with its cutting-edge AI Facial Age-Based Health Risk Estimator-a breakthrough diagnostic tool at the intersection of artificial intelligence, computer vision, and personalized medicine.
This sophisticated platform analyzes facial imagery to extract biometric markers such as micro-wrinkle density, skin elasticity, and tone variance, then applies machine learning algorithms to estimate biological age and assess predisposition to chronic conditions like cardiovascular disease and type 2 diabetes. The tool enables real-time, non-invasive screening by integrating visual facial data with predictive biomarkers, offering scalable diagnostics through mobile apps.
This innovation marks a fundamental shift in how preventive health is approached-moving away from reactive care and toward proactive, data-driven wellness management. With the global preventive health market projected to exceed
About Us
Medical Care Technologies Inc. (OTC Pink:MDCE) is a diversified technology-driven health and lifestyle company focused on revolutionizing preventive care and wellness through advanced AI solutions. Its core initiatives include real-time facial and skin diagnostics for early detection and health optimization.
MDCE is also the parent company of two incredible subsidiaries that you should inquire about:
Infinite Auctions, a premier marketplace for high-value sports memorabilia, including game-worn collectibles from legends like Michael Jordan, LeBron James, and Kobe Bryant.
Real Game Used (RGU), an industry leader in game-used item authentication and photo-matching using proprietary AI image scanning technologies that boost trust, value, and liquidity across the collectibles space.
Together, these divisions reflect MDCE's multi-industry growth strategy-delivering technological innovation, entertainment, and authenticity at scale.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Medical Care Technologies Inc. undertakes no obligation to update these statements in the future.
For more information, visit:
www.medicalcaretechnologies.com
www.infiniteauctions.com
www.realgameused.com
Investor Relations: www.mdcestock.com
Investor & Media Contact:
Infinite Auctions / MDCE
info@infiniteauctions.com
SOURCE: (OTC PINK:MDCE) Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What is Medical Care Technologies' (MDCE) new AI health technology?
How does MDCE's AI facial analysis technology work?
What medical conditions can MDCE's AI technology detect?
What is the market potential for MDCE's preventive health technology?
How will MDCE's technology be accessible to users?
